Arthritis Drugs Could Treat Persistent COVID Lung Complications
New research suggests that existing FDA-approved medications may help treat lingering lung complications caused by COVID-19 by disrupting harmful immune responses.
Tag: pharmaceuticals
All
Latest
All
Latest
FDA OKs Updated Moderna and Pfizer-BioNTech COVID-19 Vaccines
The FDA has approved and authorized updated Moderna and Pfizer-BioNTech COVID-19 vaccines for the 2024-2025 season, designed to target current variants.
All
Latest
FDA Fast Tracks Gamma Delta T-Cell Therapy for Advanced Lung Cancer
The FDA granted Fast Track designation to Deltacel, a Gamma Delta T-cell therapy being developed for the treatment of advanced non-small cell lung cancer.
Merck Stops Late-Stage Trial of Vibostolimab-Pembrolizumab Combo in Small Cell Lung Cancer
The phase 3 trial was investigating the vibostolimab and pembrolizumab combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer.
Read More
FDA Approves First Nalmefene Auto-Injector for Opioid Overdose Treatment
The FDA approved Zurnai, a nalmefene hydrochloride auto-injector, for emergency opioid overdose treatment in individuals aged 12 and older.
Read More
Semaglutide Might Be Beneficial for Smoking Cessation
Semaglutide was associated with a lower risk of medical care related to tobacco use disorder in smokers with type 2 diabetes.
Read More
Could Arthritis Drugs Alleviate Long COVID Lung Symptoms?
Researchers have identified a potential treatment for the respiratory symptoms of long COVID by discovering an unknown cause of the condition within the lungs.
Read More
FDA Grants Orphan Drug Status to Pulmonary Arterial Hypertension Treatment
ZMA001, in development for pulmonary arterial hypertension, has been designated as an Orphan Drug by the US Food and Drug Administration.
Read More
EMA Backs New Use of Melatonin Drug for Children with Insomnia and Neurogenetic Disorders
The European Medicines Agency’s CHMP recommended expanding the use of a melatonin-based treatment to help children with neurogenetic disorders manage insomnia.
Read More
WHO Initiative Aims to Accelerate mRNA Vaccine Development for Avian Influenza
The project aims to enhance pandemic preparedness by accelerating the development and accessibility of mRNA-based avian influenza vaccines for low- and middle-income countries.
Read More
FDA Expands Approval of Palforzia for Peanut Allergy Treatment in Children
Palforzia is now approved for treating peanut allergies in children ages 1 to 3, expanding its use beyond the previous age range of 4 to 17.
Read More
The CDC’s Test for Bird Flu Works, but It Has Issues
The Centers for Disease Control and Prevention says a glitch in its bird flu test hasn’t harmed the agency’s outbreak response.
Read More
Merck’s Investigational RSV Shot Protects Infants in Phase 2b/3 Trial
The trial showed that clesrovimab reduced RSV-related respiratory infections in infants through day 150.
Read More
Whooping Cough Makes a Comeback as Cases Return to Pre-Pandemic Levels
The CDC reports an increase in whooping cough cases in the US, urging vaccination to curb the spread and protect vulnerable populations.
Read More
‘Snot Bots’ Break Through Mucus Barriers for More Effective Drug Delivery
Researchers have developed enzyme-powered nanobots capable of navigating through mucus barriers—which typically keep out locally administered drug treatments.
Read More